Shunchi Wu

Pre-clinical Research Director at Gongwin Biopharm Holdings Co.,Ltd
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Taiwan, TW

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Taiwan
    • Biotechnology Research
    • 1 - 100 Employee
    • Pre-clinical Research Director
      • Nov 2017 - Present

      Preclinical drug development including drug MOA/Efficacy/PK/Tox/TK studies. Preclinical in-house in vitro and in vivo studies. Preclinical CRO evaluation, study plans and management. Module 4 (preclinical part) of investigator brochure preparation. Meeting with regulatory authority including pre-IND, EOP I, EOP II and pre-NDA. For the regulatory authority requirements to plan and conduct the suitable studies including repeated tox., impurities safety, in vitro DDIs and in vitro ADME studies. New drug evaluation and license-in process. New patents application, OA and maintenance. Creative projects finding and developing. Scientific studies through academic cooperation for publications. Pet clinical plans and case report forms writing and preparation. Supporting of the medical and marketing department function. Show less

    • RD Associate Director
      • Aug 2017 - Oct 2017

    • Manager, Products R&D Department
      • Aug 2015 - Aug 2017

    • Scientist
      • Apr 2012 - Aug 2015

    • Associate Scientist
      • Aug 2011 - Apr 2012

    • Postdoctoral Research Fellow
      • Oct 2010 - Jul 2011

    • Research Services
    • 400 - 500 Employee
    • Postdoctoral Research Fellow
      • Oct 2009 - Oct 2010

Education

  • 國立臺灣大學
    Ph.D., Institute of Biochemistry and Molecular Biology
    2001 - 2008
  • 國立臺灣大學
    M. S., Institute of Biochemical Sciences
    1999 - 2001
  • 臺北醫學大學
    B. S., School of Nutrition and Health Sciences
    1995 - 1999

Community

You need to have a working account to view this content. Click here to join now